US Stock MarketDetailed Quotes
MCRB Seres Therapeutics
- 0.760
- +0.135+21.68%
Close Apr 23 16:00 ET
114.77MMarket Cap-853P/E (TTM)
0.803High0.629Low11.88MVolume0.639Open0.625Pre Close8.78MTurnover9.97%Turnover RatioLossP/E (Static)151.01MShares6.26052wk High-2.56P/B90.53MFloat Cap0.54052wk Low--Dividend TTM119.11MShs Float52.000Historical High--Div YieldTTM27.87%Amplitude0.540Historical Low0.739Avg Price1Lot Size
About Seres Therapeutics Company
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.
Company Profile
SymbolMCRB
Company NameSeres Therapeutics
Listing DateJun 26, 2015
Issue Price18.00
Founded2010
CEOMr. Eric D. Shaff
MarketNASDAQ
Employees233
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address200 Sidney Street,4th floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-945-9626
Company Executives
- Name
- Position
- Salary
- Eric D. Shaff
- Director, President, Chief Executive Officer, Interim Principal Financial Officer and Principal Accounting Officer
- 3.16M
- Thomas J. DesRosier
- Executive Vice President, Chief Legal Officer and Secretary
- 1.84M
- Dr. Teresa L. Young, PhD
- Executive Vice President, Chief Commercial and Strategy Officer
- 1.82M
- Dr. Matthew Henn, PhD
- Executive Vice President and Chief Scientific Officer
- --
- Dr. David S. Ege, PhD
- Executive Vice President and Chief Technology Officer
- --
- Dr. Lisa von Moltke, M.D.
- Executive Vice President and Chief Medical Officer
- 1.57M
- Stephen Berenson
- Chairman of the Board
- 249.23K
- Dr. Willard H. Dere, M.D.
- Independent Director
- 225.23K
- Paul R. Biondi
- Independent Director
- 211.73K
- Richard N. Kender, M.B.A.
- Independent Director
- 232.69K
- Dr. Dennis A. Ausiello, M.D.
- Independent Director
- 222.27K
- Kurt C. Graves
- Independent Director
- 219.23K
- Dr. Claire M. Fraser, PhD
- Independent Director
- 438.15K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
